Article
Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.
Journal of cellular and molecular medicine - 1 Jan 2021
Gao Feng, Li Ming, Yu Xinfang, Liu Wenbin, Zhou Li, Li Wei
Abstract excerpt
Dysfunction of epidermal growth factor receptor (EGFR) signalling plays a critical role in the oncogenesis of non-small-cell lung cancer (NSCLC). Here, we reported the natural product, licochalcone A, exhibited a profound anti-tumour efficacy through directly targeting EGFR signalling. Licochalcone A inhibited in vitro cell growth, colony formation and in vivo tumour growth of either wild-type (WT) or activating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
